Tested in patients with the latent form of tuberculosis, the vaccine prevented the development of the active form of infection in 50 percent more individuals compared with unvaccinated patients.

An early-stage, blood-based assay shows potential as a method for sorting patients with suspected TB from those with other respiratory illnesses.

The agency joins a group of funders, cOAlition S, that supports making publications immediately available to the public for free.

REGN-EB3 and mAb114 reduced mortality in a clinical trial carried out during the ongoing outbreak in Democratic Republic of Congo.

Deaths attributed to the disease have outpaced those from Ebola this year.

Delivery guidelines should be updated to reflect these results, the authors write.

The World Health Organization and its partners will test the public health effect of immunization in parts of Malawi, Ghana, and Kenya.

The agency also shares preliminary results of an Ebola vaccine trial showing that it is 97.5 percent effective at protecting from infection.

The advisors’ recommendations follow news of ethically dubious gene-editing work carried out by He Jiankui late last year.